MYD88 and inflammatory response: Dexmedetomidine (10and 20 μg/kg) significantly decreased mortality and pulmonary inflammation of septic rats, as well as suppressed CLP-induced elevation ofTNF-α and IL-6 and inhibited TLR4/MyD88 expression and NF-κB activation.